img

Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

T Cell Surface Glycoprotein CD3 Epsilon Chain report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global T Cell Surface Glycoprotein CD3 Epsilon Chain market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Autoimmune Disorders and Hepatitis B are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for T Cell Surface Glycoprotein CD3 Epsilon Chain industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, T Cell Surface Glycoprotein CD3 Epsilon Chain key companies include Amgen Inc, Celgene Corp, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, MacroGenics Inc, Meridigen Biotech Co Ltd, Numab Innovation AG, SYNIMMUNE GmbH and Tiziana Life Sciences Plc, etc. Amgen Inc, Celgene Corp, F. Hoffmann-La Roche Ltd are top 3 players and held % share in total in 2022.
T Cell Surface Glycoprotein CD3 Epsilon Chain can be divided into ND-007, Foralumab, Coltelizumab and AVA-002, etc. ND-007 is the mainstream product in the market, accounting for % share globally in 2022.
T Cell Surface Glycoprotein CD3 Epsilon Chain is widely used in various fields, such as Autoimmune Disorders, Hepatitis B, Multiple Sclerosis and Prostate Cancer, etc. Autoimmune Disorders provides greatest supports to the T Cell Surface Glycoprotein CD3 Epsilon Chain industry development. In 2022, global % share of T Cell Surface Glycoprotein CD3 Epsilon Chain went into Autoimmune Disorders filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global T Cell Surface Glycoprotein CD3 Epsilon Chain market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Amgen Inc
Celgene Corp
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
MacroGenics Inc
Meridigen Biotech Co Ltd
Numab Innovation AG
SYNIMMUNE GmbH
Tiziana Life Sciences Plc
Segment by Type
ND-007
Foralumab
Coltelizumab
AVA-002
Others

Segment by Application


Autoimmune Disorders
Hepatitis B
Multiple Sclerosis
Prostate Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the T Cell Surface Glycoprotein CD3 Epsilon Chain market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, T Cell Surface Glycoprotein CD3 Epsilon Chain introduction, etc. T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of T Cell Surface Glycoprotein CD3 Epsilon Chain market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of T Cell Surface Glycoprotein CD3 Epsilon Chain
1.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Overview
1.1.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Scope
1.1.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Status and Outlook
1.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2018-2034)
1.4 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Historic Market Size by Region (2018-2024)
1.5 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast by Region (2024-2034)
1.6 Key Regions, T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034)
1.6.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034)
1.6.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034)
1.6.3 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034)
1.6.4 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034)
1.6.5 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034)
2 T Cell Surface Glycoprotein CD3 Epsilon Chain Market by Type
2.1 Introduction
2.1.1 ND-007
2.1.2 Foralumab
2.1.3 Coltelizumab
2.1.4 AVA-002
2.1.5 Others
2.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Historic Market Size by Type (2018-2024)
2.2.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Breakdown by Type (2018-2034)
2.3.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Breakdown by Type (2018-2034)
3 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Overview by Application
3.1 Introduction
3.1.1 Autoimmune Disorders
3.1.2 Hepatitis B
3.1.3 Multiple Sclerosis
3.1.4 Prostate Cancer
3.1.5 Others
3.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Historic Market Size by Application (2018-2024)
3.2.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Breakdown by Application (2018-2034)
3.3.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Breakdown by Application (2018-2034)
4 T Cell Surface Glycoprotein CD3 Epsilon Chain Competition Analysis by Players
4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain as of 2022)
4.3 Date of Key Players Enter into T Cell Surface Glycoprotein CD3 Epsilon Chain Market
4.4 Global Top Players T Cell Surface Glycoprotein CD3 Epsilon Chain Headquarters and Area Served
4.5 Key Players T Cell Surface Glycoprotein CD3 Epsilon Chain Product Solution and Service
4.6 Competitive Status
4.6.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Amgen Inc
5.1.1 Amgen Inc Profile
5.1.2 Amgen Inc Main Business
5.1.3 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
5.1.4 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$ Million) & (2018-2024)
5.1.5 Amgen Inc Recent Developments
5.2 Celgene Corp
5.2.1 Celgene Corp Profile
5.2.2 Celgene Corp Main Business
5.2.3 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
5.2.4 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$ Million) & (2018-2024)
5.2.5 Celgene Corp Recent Developments
5.3 F. Hoffmann-La Roche Ltd
5.3.1 F. Hoffmann-La Roche Ltd Profile
5.3.2 F. Hoffmann-La Roche Ltd Main Business
5.3.3 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
5.3.4 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$ Million) & (2018-2024)
5.3.5 GlaxoSmithKline Plc Recent Developments
5.4 GlaxoSmithKline Plc
5.4.1 GlaxoSmithKline Plc Profile
5.4.2 GlaxoSmithKline Plc Main Business
5.4.3 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
5.4.4 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$ Million) & (2018-2024)
5.4.5 GlaxoSmithKline Plc Recent Developments
5.5 MacroGenics Inc
5.5.1 MacroGenics Inc Profile
5.5.2 MacroGenics Inc Main Business
5.5.3 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
5.5.4 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$ Million) & (2018-2024)
5.5.5 MacroGenics Inc Recent Developments
5.6 Meridigen Biotech Co Ltd
5.6.1 Meridigen Biotech Co Ltd Profile
5.6.2 Meridigen Biotech Co Ltd Main Business
5.6.3 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
5.6.4 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$ Million) & (2018-2024)
5.6.5 Meridigen Biotech Co Ltd Recent Developments
5.7 Numab Innovation AG
5.7.1 Numab Innovation AG Profile
5.7.2 Numab Innovation AG Main Business
5.7.3 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
5.7.4 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$ Million) & (2018-2024)
5.7.5 Numab Innovation AG Recent Developments
5.8 SYNIMMUNE GmbH
5.8.1 SYNIMMUNE GmbH Profile
5.8.2 SYNIMMUNE GmbH Main Business
5.8.3 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
5.8.4 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$ Million) & (2018-2024)
5.8.5 SYNIMMUNE GmbH Recent Developments
5.9 Tiziana Life Sciences Plc
5.9.1 Tiziana Life Sciences Plc Profile
5.9.2 Tiziana Life Sciences Plc Main Business
5.9.3 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
5.9.4 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$ Million) & (2018-2024)
5.9.5 Tiziana Life Sciences Plc Recent Developments
6 North America
6.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Dynamics
11.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Industry Trends
11.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Drivers
11.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Challenges
11.4 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Share by Region (2018-2024)
Table 4. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size Share by Region (2024-2034)
Table 6. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2018-2024)
Table 9. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2024-2034)
Table 11. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2018-2024)
Table 24. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2024-2034)
Table 26. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$ Million) by Players (2018-2024)
Table 37. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain as of 2022)
Table 39. Date of Key Players Enter into T Cell Surface Glycoprotein CD3 Epsilon Chain Market
Table 40. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Key Players Headquarters and Area Served
Table 41. T Cell Surface Glycoprotein CD3 Epsilon Chain Product Solution and Service
Table 42. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Amgen Inc Basic Information List
Table 45. Amgen Inc Description and Business Overview
Table 46. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
Table 47. Revenue (US$ Million) in T Cell Surface Glycoprotein CD3 Epsilon Chain Business of Amgen Inc (2018-2024)
Table 48. Amgen Inc Recent Developments
Table 49. Celgene Corp Basic Information List
Table 50. Celgene Corp Description and Business Overview
Table 51. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
Table 52. Revenue (US$ Million) in T Cell Surface Glycoprotein CD3 Epsilon Chain Business of Celgene Corp (2018-2024)
Table 53. Celgene Corp Recent Developments
Table 54. F. Hoffmann-La Roche Ltd Basic Information List
Table 55. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 56. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
Table 57. Revenue (US$ Million) in T Cell Surface Glycoprotein CD3 Epsilon Chain Business of F. Hoffmann-La Roche Ltd (2018-2024)
Table 58. F. Hoffmann-La Roche Ltd Recent Developments
Table 59. GlaxoSmithKline Plc Basic Information List
Table 60. GlaxoSmithKline Plc Description and Business Overview
Table 61. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
Table 62. Revenue (US$ Million) in T Cell Surface Glycoprotein CD3 Epsilon Chain Business of GlaxoSmithKline Plc (2018-2024)
Table 63. GlaxoSmithKline Plc Recent Developments
Table 64. MacroGenics Inc Basic Information List
Table 65. MacroGenics Inc Description and Business Overview
Table 66. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
Table 67. Revenue (US$ Million) in T Cell Surface Glycoprotein CD3 Epsilon Chain Business of MacroGenics Inc (2018-2024)
Table 68. MacroGenics Inc Recent Developments
Table 69. Meridigen Biotech Co Ltd Basic Information List
Table 70. Meridigen Biotech Co Ltd Description and Business Overview
Table 71. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
Table 72. Revenue (US$ Million) in T Cell Surface Glycoprotein CD3 Epsilon Chain Business of Meridigen Biotech Co Ltd (2018-2024)
Table 73. Meridigen Biotech Co Ltd Recent Developments
Table 74. Numab Innovation AG Basic Information List
Table 75. Numab Innovation AG Description and Business Overview
Table 76. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
Table 77. Revenue (US$ Million) in T Cell Surface Glycoprotein CD3 Epsilon Chain Business of Numab Innovation AG (2018-2024)
Table 78. Numab Innovation AG Recent Developments
Table 79. SYNIMMUNE GmbH Basic Information List
Table 80. SYNIMMUNE GmbH Description and Business Overview
Table 81. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
Table 82. Revenue (US$ Million) in T Cell Surface Glycoprotein CD3 Epsilon Chain Business of SYNIMMUNE GmbH (2018-2024)
Table 83. SYNIMMUNE GmbH Recent Developments
Table 84. Tiziana Life Sciences Plc Basic Information List
Table 85. Tiziana Life Sciences Plc Description and Business Overview
Table 86. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Products, Services and Solutions
Table 87. Revenue (US$ Million) in T Cell Surface Glycoprotein CD3 Epsilon Chain Business of Tiziana Life Sciences Plc (2018-2024)
Table 88. Tiziana Life Sciences Plc Recent Developments
Table 89. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2018-2024) & (US$ Million)
Table 90. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2024-2034) & (US$ Million)
Table 91. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2018-2024) & (US$ Million)
Table 92. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2024-2034) & (US$ Million)
Table 93. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 94. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2018-2024) & (US$ Million)
Table 95. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2024-2034) & (US$ Million)
Table 96. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Region (2018-2024)
Table 97. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Region (2024-2034)
Table 98. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 99. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2018-2024) & (US$ Million)
Table 100. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2024-2034) & (US$ Million)
Table 101. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 102. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2018-2024) & (US$ Million)
Table 103. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2024-2034) & (US$ Million)
Table 104. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Trends
Table 105. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Drivers
Table 106. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Challenges
Table 107. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Regions: 2022 VS 2034
Figure 4. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of ND-007
Figure 11. Global ND-007 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Foralumab
Figure 13. Global Foralumab Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of Coltelizumab
Figure 15. Global Coltelizumab Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Product Picture of AVA-002
Figure 17. Global AVA-002 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 18. Product Picture of Others
Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 20. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Share by Type: 2022 & 2034
Figure 21. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2018-2034)
Figure 22. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2018-2034)
Figure 23. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2018-2034)
Figure 24. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2018-2034)
Figure 25. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2018-2034)
Figure 26. Autoimmune Disorders Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 27. Hepatitis B Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 28. Multiple Sclerosis Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 29. Prostate Cancer Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 30. Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 31. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Share by Application: 2022 & 2034
Figure 32. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2018-2034)
Figure 33. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2018-2034)
Figure 34. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2018-2034)
Figure 35. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2018-2034)
Figure 36. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2018-2034)
Figure 37. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 38. Global Top 5 and Top 10 Players T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share in 2022
Figure 39. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Country (2018-2034)
Figure 40. U.S. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 41. Canada T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 42. Germany T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 43. France T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 44. U.K. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 45. Italy T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 46. Russia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 47. Nordic Countries T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 48. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Region (2018-2034)
Figure 49. China T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 50. Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 51. South Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 52. Southeast Asia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 53. India T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 54. Australia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 55. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Country (2018-2034)
Figure 56. Mexico T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 57. Brazil T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 58. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Country (2018-2034)
Figure 59. Turkey T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 60. Saudi Arabia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 61. UAE T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034) & (US$ Million)
Figure 62. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries